UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 115

Sortiert nach

Dapagliflozin Added to Usual Care in Individuals with Type 2 Diabetes Mellitus with Preexisting Cardiovascular Disease: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study with a 28-Week Extension

Journal of the American Geriatrics Society (JAGS), 2014-07, Vol.62 (7), p.1252-1262

2014

Volltextzugriff (PDF)

Safety Profile of Dapagliflozin for Type 2 Diabetes: Pooled Analysis of Clinical Studies for Overall Safety and Rare Events

Drug safety, 2014-10, Vol.37 (10), p.815-829

2014

Volltextzugriff (PDF)

Cardiovascular safety assessment of pramlintide in type 2 diabetes: results from a pooled analysis of five clinical trials

Clinical diabetes and endocrinology, 2016-05, Vol.2 (1), p.12-12, Article 12

2016

Volltextzugriff (PDF)

nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemia

Human genetics, 2010-01, Vol.127 (1), p.83-89

2010

Volltextzugriff (PDF)

Dapagliflozin's Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension

Diabetes care, 2015-07, Vol.38 (7), p.1218-1227

2015

Volltextzugriff (PDF)

Activating Transcription Factor 6 Polymorphisms and Haplotypes Are Associated with Impaired Glucose Homeostasis and Type 2 Diabetes in Dutch Caucasians

The journal of clinical endocrinology and metabolism, 2007-07, Vol.92 (7), p.2720-2725

2007

Volltextzugriff (PDF)

WW-Domain-Containing Oxidoreductase Is Associated with Low Plasma HDL-C Levels

American journal of human genetics, 2008-08, Vol.83 (2), p.180-192

2008

Volltextzugriff (PDF)

Association of stearoyl-CoA desaturase 1 activity with familial combined hyperlipidemia

Arteriosclerosis, thrombosis, and vascular biology, 2008-06, Vol.28 (6), p.1193

2008

Volltextzugriff (PDF)

Heritability and genetic loci of fatty liver in familial combined hyperlipidemia

Journal of lipid research, 2006-12, Vol.47 (12), p.2799-2807

2006

Volltextzugriff (PDF)

Bioequivalence of fixed-dose combinations of dapagliflozin and metformin with single-component tablets in healthy subjects and the effect of food on bioavailability

Clinical pharmacology in drug development, 2016-03, Vol.5 (2), p.118-130

2016

Volltextzugriff (PDF)

Fatty liver is an integral feature of familial combined hyperlipidaemia: relationship with fat distribution and plasma lipids

Clinical science (1979), 2007-01, Vol.112 (2), p.123

2007

Volltextzugriff (PDF)

Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial

Journal of clinical lipidology, 2018-03, Vol.12 (2), p.321-330

2018

Volltextzugriff (PDF)

Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?

Clinical science (1979), 2008-03, Vol.114 (5), p.393

2008

Volltextzugriff (PDF)

Galanin preproprotein is associated with elevated plasma triglycerides

Arteriosclerosis, thrombosis, and vascular biology, 2009-01, Vol.29 (1), p.147

2009

Volltextzugriff (PDF)

USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease

Arteriosclerosis, thrombosis, and vascular biology, 2007-10, Vol.27 (10), p.2222

2007

Volltextzugriff (PDF)

Combined Analysis of Genome Scans of Dutch and Finnish Families Reveals a Susceptibility Locus for High-Density Lipoprotein Cholesterol on Chromosome 16q

American journal of human genetics, 2003-04, Vol.72 (4), p.903-917

2003

Volltextzugriff (PDF)

Effects of interacting networks of cardiovascular risk genes on the risk of type 2 diabetes mellitus (the CODAM study)

BMC medical genetics, 2008-04, Vol.9 (1), p.36-36, Article 36

2008

Volltextzugriff (PDF)

Abdominal obesity and expression of familial combined hyperlipidemia

Obesity (Silver Spring, Md.), 2004-12, Vol.12 (12), p.2054-2061

2004

Volltextzugriff (PDF)

Validation of a Quantitative Magnetic Resonance Method for Measuring Human Body Composition

Obesity (Silver Spring, Md.), 2008-01, Vol.16 (1), p.191-198

2008

Volltextzugriff (PDF)

Upstream transcription factor 1 (USF1) in risk of type 2 diabetes: Association study in 2000 Dutch Caucasians

Molecular genetics and metabolism, 2008-07, Vol.94 (3), p.352-355

2008

Volltextzugriff (PDF)

Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia

Clinical science (1979), 2007-11, Vol.113 (9), p.375

2007

Volltextzugriff (PDF)

Lifestyle Intervention According to General Recommendations Improves Glucose Tolerance

Obesity (Silver Spring, Md.), 2003-12, Vol.11 (12), p.1588-1596

2003

Volltextzugriff (PDF)

Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein E

Thrombosis research, 2008-01, Vol.122 (4), p.466-472

2008

Volltextzugriff (PDF)

Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B

Arteriosclerosis, thrombosis, and vascular biology, 2002-02, Vol.22 (2), p.283

2002

Volltextzugriff (PDF)

The ATF6-Met[67]Val substitution is associated with increased plasma cholesterol levels

Arteriosclerosis, thrombosis, and vascular biology, 2009-09, Vol.29 (9), p.1322

2009

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(114)
Tagungsberichte
(1)

Sprache

Englisch
(115)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Humans
(99)
Life Sciences & Biomedicine
(95)
Science & Technology
(95)
Male
(71)
Female
(69)
Biological And Medical Sciences
(65)
Middle Aged
(63)
Medical Sciences
(60)
Adult
(53)
Cardiovascular System & Cardiology
(33)
Hyperlipidemia, Familial Combined - Genetics
(33)
Peripheral Vascular Disease
(31)
Metabolic Diseases
(27)
Disorders Of Blood Lipids. Hyperlipoproteinemia
(26)
Triglycerides - Blood
(26)
Endocrinology & Metabolism
(23)
Hyperlipidemia, Familial Combined - Blood
(21)
Familial Combined Hyperlipidemia
(20)
Cardiac & Cardiovascular Systems
(17)
Aged
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dapagliflozin Added to Usual Care in Individuals with Type 2 Diabetes Mellitus with Preexisting Cardiovascular Disease: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study with a 28-Week Extension

Safety Profile of Dapagliflozin for Type 2 Diabetes: Pooled Analysis of Clinical Studies for Overall Safety and Rare Events

Cardiovascular safety assessment of pramlintide in type 2 diabetes: results from a pooled analysis of five clinical trials

nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemia

Dapagliflozin's Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension

Activating Transcription Factor 6 Polymorphisms and Haplotypes Are Associated with Impaired Glucose Homeostasis and Type 2 Diabetes in Dutch Caucasians

WW-Domain-Containing Oxidoreductase Is Associated with Low Plasma HDL-C Levels

Association of stearoyl-CoA desaturase 1 activity with familial combined hyperlipidemia

Heritability and genetic loci of fatty liver in familial combined hyperlipidemia

Bioequivalence of fixed-dose combinations of dapagliflozin and metformin with single-component tablets in healthy subjects and the effect of food on bioavailability

Fatty liver is an integral feature of familial combined hyperlipidaemia: relationship with fat distribution and plasma lipids

Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial

Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?

Galanin preproprotein is associated with elevated plasma triglycerides

USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease

Combined Analysis of Genome Scans of Dutch and Finnish Families Reveals a Susceptibility Locus for High-Density Lipoprotein Cholesterol on Chromosome 16q

Effects of interacting networks of cardiovascular risk genes on the risk of type 2 diabetes mellitus (the CODAM study)

Abdominal obesity and expression of familial combined hyperlipidemia

Validation of a Quantitative Magnetic Resonance Method for Measuring Human Body Composition

Upstream transcription factor 1 (USF1) in risk of type 2 diabetes: Association study in 2000 Dutch Caucasians

Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia

Lifestyle Intervention According to General Recommendations Improves Glucose Tolerance

Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein E

Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B

The ATF6-Met[67]Val substitution is associated with increased plasma cholesterol levels

Suchergebnisse filtern